Literature DB >> 21135725

Long-lasting, complete exclusion of a large galenic dural arteriovenous fistula after clipping of the central venous aneurysm of the vein of galen: case report.

Steven De Vleeschouwer1, Charles-Albert Smets, Guido Wilms.   

Abstract

BACKGROUND AND IMPORTANCE: Galenic dural arteriovenous fistulas (DAVFs) are a subtype of the rare falcotentorial DAVFs with a high risk of hemorrhage and an aggressive clinical course. Microsurgical treatment is often necessary because endovascular obliteration will rarely completely obliterate the DAVF. CLINICAL
PRESENTATION: We present a unique case of a complex, ruptured galenic DAVF in which the key point of the fistula was formed by a large venous aneurysm of the vein of Galen. A session of embolization of the falcotentorial feeding vessels followed by additional surgical transsection of the remaining tentorial arterial feeders failed to exclude the galenic DAVF. Direct clipping of the venous aneurysm through a unilateral occipital craniotomy for a posterior interhemispheric transtentorial approach resulted in an ongoing radiological complete obliteration in this patient, who made an uneventful complete recovery after 2 subarachnoid hemorrhages, which he suffered before this definitive treatment.
CONCLUSION: Direct interruption of the fistula key point by clipping of the venous aneurysm, rather than interruption of the feeding vessels, was mandatory for complete exclusion of this complex galenic DAVF.

Entities:  

Mesh:

Year:  2011        PMID: 21135725     DOI: 10.1227/NEU.0b013e318202088a

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Galenic dural arteriovenous fistula in neurofibromatosis type 1 treated with Onyx.

Authors:  Zongli Han; Yanli Du; Hui Qi
Journal:  Interv Neuroradiol       Date:  2019-05-31       Impact factor: 1.610

2.  Endovascular treatment of vein of Galen dural arteriovenous fistula presenting as dementia.

Authors:  Vikram Huded; Syed Zafer Moeed; Romnesh Desouza; Ravikesh Tripathi; Rithesh Nair
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.